[Featured Stock] GST to Begin Vaccinations from February... Subsidiary EST's Cold Chain Technology Highlighted

[Asia Economy Reporter Yoo Hyun-seok] GST is showing strong performance. The subsidiary EST's cold chain technology has gained attention as COVID-19 vaccinations are expected to begin as early as next month, which appears to have influenced this trend.

As of 2:45 AM on the 7th, GST was trading at 17,650 KRW, up 4.75% (800 KRW) compared to the previous trading day.

On the previous day, Hong Nam-ki, Deputy Prime Minister and Minister of Economy and Finance, stated at the 'Emergency Economic Central Countermeasures Headquarters Meeting and Korean New Deal Ministerial Meeting' held at the Government Seoul Office Complex, "Rapid execution of vaccine procurement is the key issue," adding, "We plan to continue disbursing approximately 1 trillion KRW, including the advance payment for 20 million doses of Moderna vaccines." He further added, "We will prepare to start vaccinations from February."

GST had previously attracted attention regarding the transportation of COVID-19 vaccines and diagnostic kits. Its subsidiary, EST, in which the company holds a 70.59% stake, has a cold storage system using phase change materials (PCM) that can maintain desired refrigerated and frozen temperatures. This is because they were commissioned by the Indonesian government to provide solutions for transporting COVID-19 vaccines and diagnostic kits.

This content was produced with the assistance of AI translation services.